UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 353

Sortiert nach

Radiosensitization by BRAF inhibitor therapy—mechanism and frequency of toxicity in melanoma patients

Annals of oncology, 2015-06, Vol.26 (6), p.1238-1244

2015

Volltextzugriff (PDF)

Characteristics, risk factors and treatment reality in livedoid vasculopathy – a multicentre analysis

Journal of the European Academy of Dermatology and Venereology, 2019-09, Vol.33 (9), p.1784-1791

2019

Volltextzugriff (PDF)

Treatment of Chronic Pruritus with the Selective Serotonin Re-uptake Inhibitors Paroxetine and Fluvoxamine : Results of an Open-labelled, Two-arm Proof-of-concept Study

Acta dermato-venereologica, 2009, Vol.89 (1), p.45-51

2009

Volltextzugriff (PDF)

Phase I dose-escalation and expansion study of intratumoral CV8102, a RNA-based TLR- and RIG-1 agonist in patients with advanced solid tumors

Annals of oncology, 2018-10, Vol.29, p.viii466-viii466

2018

Volltextzugriff (PDF)

Lack of protection from development of multiple melanomas by an injected melanocortin analogue in a combined high-risk MC1R/CDKN2A genotype patient

Journal of the European Academy of Dermatology and Venereology, 2016-10, Vol.30 (10), p.e65-e67

2016

Volltextzugriff (PDF)

Evaluation of the German guideline for chronic pruritus: results of a retrospective study on 385 patients

Dermatology (Basel), 2011-01, Vol.223 (4), p.374

2011

Volltextzugriff (PDF)

PO-0922: De-escalated radiotherapy for indolent primary cutaneous B-cell lymphoma

Radiotherapy and oncology, 2020-11, Vol.152, p.S493-S493

2020

Volltextzugriff (PDF)

Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy

European journal of cancer (1990), 2016-06, Vol.60, p.210-225

2016

Volltextzugriff (PDF)

MO-0950 Selected soluble biomarkers in mycosis fungoides and Sézary syndrome: Final results of S-MISR trial

Radiotherapy and oncology, 2023-05, Vol.182, p.S798-S799

2023

Volltextzugriff (PDF)

Quality of Life Improvement Following Low-Dose Total Skin Electron Beam Therapy in Patients with Mycosis Fungoides or Sezary Syndrome

International journal of radiation oncology, biology, physics, 2019-09, Vol.105 (1), p.S245-S245

2019

Volltextzugriff (PDF)

1079P Comparison of effectiveness and safety of nivolumab monotherapy or in combination therapy with ipilimumab in therapy-naïve and pretreated patients with advanced melanoma within the German noninterventional study NICO

Annals of oncology, 2021-09, Vol.32, p.S894-S895

2021

Volltextzugriff (PDF)

1104P Nivolumab (NIVO) monotherapy or combination therapy with ipilimumab (NIVO+IPI) in advanced melanoma patients with brain metastases: Real-world evidence from the German non-interventional study NICO

Annals of oncology, 2020-09, Vol.31, p.S746-S747

2020

Volltextzugriff (PDF)

1010P Intratumorally administered CV8102 in patients with advanced solid tumors: Preliminary results from completed dose escalation in study 008

Annals of oncology, 2021-09, Vol.32, p.S853-S853

2021

Volltextzugriff (PDF)

Paired Basic Amino Acid-cleaving Enzyme 4 (PCSK6): An Emerging New Target Molecule in Human Melanoma

Acta dermato-venereologica, 2020-05, Vol.100 (10), p.adv00157

2020

Volltextzugriff (PDF)

Outcome of patients with elevated LDH treated with first-line targeted therapy (TT) or PD-1 based immune checkpoint inhibitors (ICI)

Annals of oncology, 2019-10, Vol.30, p.v549-v550

2019

Volltextzugriff (PDF)

1345P - Outcome of patients with elevated LDH treated with first-line targeted therapy (TT) or PD-1 based immune checkpoint inhibitors (ICI)

Annals of oncology, 2019-10, Vol.30, p.v549-v550

2019

Volltextzugriff (PDF)

1345POutcome of patients with elevated LDH treated with first-line targeted therapy (TT) or PD-1 based immune checkpoint inhibitors (ICI)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

1305TiPPhase I dose-escalation and expansion study of intratumoral CV8102, a RNA-based TLR- and RIG-1 agonist in patients with advanced solid tumors

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

509TiPA phase I dose-escalation and expansion trial of intratumorally administered CV8102, alone and in combination with anti-PD-1 in patients with advanced solid tumours

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

509TiP - A phase I dose-escalation and expansion trial of intratumorally administered CV8102, alone and in combination with anti-PD-1 in patients with advanced solid tumours

Annals of oncology, 2019-10, Vol.30, p.v191-v192

2019

Volltextzugriff (PDF)

A phase I dose-escalation and expansion trial of intratumorally administered CV8102, alone and in combination with anti-PD-1 in patients with advanced solid tumours

Annals of oncology, 2019-10, Vol.30, p.v191-v192

2019

Volltextzugriff (PDF)

Clara-Cell Hyperplasia After Quartz and Coal-Dust Instillation in Rat Lung

Inhalation toxicology, 2001-03, Vol.13 (3), p.191-205

Catrin Albrecht, Brigitte Adolf, Christel Weishaupt, Doris Höhr, Isabel Zeitträger, Johannes Friemann, Paul J. A. Borm

2001

Volltextzugriff (PDF)

Surface Modification of Quartz Inhibits Toxicity, Particle Uptake, and Oxidative DNA Damage in Human Lung Epithelial Cells

Chemical research in toxicology, 2002-09, Vol.15 (9), p.1166-1173

2002

Volltextzugriff (PDF)

A spectrum of biophysical interaction modes between T cells and different antigen-presenting cells during priming in 3-D collagen and in vivo

Blood, 2004-11, Vol.104 (9), p.2801-2809

2004

Volltextzugriff (PDF)

Formation of PAH–DNA adducts after in vivo and vitro exposure of rats and lung cells to different commercial carbon blacks

Toxicology and applied pharmacology, 2005-06, Vol.205 (2), p.157-167

2005

Volltextzugriff (PDF)

1 – 25 von 353

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(331)
Mit Volltextzugriff
(314)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(244)
Life Sciences & Biomedicine
(231)
Humans
(156)
Female
(107)
Neurosciences & Neurology
(104)
Male
(101)
Animals
(89)
Amyotrophic Lateral Sclerosis
(88)
Neurosciences
(81)
Middle Aged
(68)
Clinical Neurology
(63)
Adult
(60)
Aged
(53)
Neurology
(45)
Amyotrophic Lateral Sclerosis - Genetics
(42)
Biological And Medical Sciences
(40)
Mutation
(38)
Medical Sciences
(36)
Mice
(33)
Medicine
(30)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of Oncology
(13)
Neurobiology Of Aging
(12)
Acta Neuropathologica
(11)
Brain
(11)
Equine Veterinary Journal
(10)
Annals Of Neurology
(9)
Journal Of Neurology, Neurosurgery And Psychiatry
(9)
Radiology
(8)
Nervenarzt
(7)
Experimental Neurology
(6)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Radiosensitization by BRAF inhibitor therapy—mechanism and frequency of toxicity in melanoma patients

Characteristics, risk factors and treatment reality in livedoid vasculopathy – a multicentre analysis

Treatment of Chronic Pruritus with the Selective Serotonin Re-uptake Inhibitors Paroxetine and Fluvoxamine : Results of an Open-labelled, Two-arm Proof-of-concept Study

Phase I dose-escalation and expansion study of intratumoral CV8102, a RNA-based TLR- and RIG-1 agonist in patients with advanced solid tumors

Lack of protection from development of multiple melanomas by an injected melanocortin analogue in a combined high-risk MC1R/CDKN2A genotype patient

Evaluation of the German guideline for chronic pruritus: results of a retrospective study on 385 patients

PO-0922: De-escalated radiotherapy for indolent primary cutaneous B-cell lymphoma

Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy

MO-0950 Selected soluble biomarkers in mycosis fungoides and Sézary syndrome: Final results of S-MISR trial

Quality of Life Improvement Following Low-Dose Total Skin Electron Beam Therapy in Patients with Mycosis Fungoides or Sezary Syndrome

1079P Comparison of effectiveness and safety of nivolumab monotherapy or in combination therapy with ipilimumab in therapy-naïve and pretreated patients with advanced melanoma within the German noninterventional study NICO

1104P Nivolumab (NIVO) monotherapy or combination therapy with ipilimumab (NIVO+IPI) in advanced melanoma patients with brain metastases: Real-world evidence from the German non-interventional study NICO

1010P Intratumorally administered CV8102 in patients with advanced solid tumors: Preliminary results from completed dose escalation in study 008

Paired Basic Amino Acid-cleaving Enzyme 4 (PCSK6): An Emerging New Target Molecule in Human Melanoma

Outcome of patients with elevated LDH treated with first-line targeted therapy (TT) or PD-1 based immune checkpoint inhibitors (ICI)

1345P - Outcome of patients with elevated LDH treated with first-line targeted therapy (TT) or PD-1 based immune checkpoint inhibitors (ICI)

1345POutcome of patients with elevated LDH treated with first-line targeted therapy (TT) or PD-1 based immune checkpoint inhibitors (ICI)

1305TiPPhase I dose-escalation and expansion study of intratumoral CV8102, a RNA-based TLR- and RIG-1 agonist in patients with advanced solid tumors

509TiPA phase I dose-escalation and expansion trial of intratumorally administered CV8102, alone and in combination with anti-PD-1 in patients with advanced solid tumours

509TiP - A phase I dose-escalation and expansion trial of intratumorally administered CV8102, alone and in combination with anti-PD-1 in patients with advanced solid tumours

A phase I dose-escalation and expansion trial of intratumorally administered CV8102, alone and in combination with anti-PD-1 in patients with advanced solid tumours

Clara-Cell Hyperplasia After Quartz and Coal-Dust Instillation in Rat Lung

Surface Modification of Quartz Inhibits Toxicity, Particle Uptake, and Oxidative DNA Damage in Human Lung Epithelial Cells

A spectrum of biophysical interaction modes between T cells and different antigen-presenting cells during priming in 3-D collagen and in vivo

Formation of PAH–DNA adducts after in vivo and vitro exposure of rats and lung cells to different commercial carbon blacks

Suchergebnisse filtern